Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$86.36 -0.13 (-0.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arrowhead Pharmaceuticals (ARWR) Prepaid Assets (2010 - 2026)

Arrowhead Pharmaceuticals' (ARWR) quarterly Prepaid Assets came in at $21.7 million in Q1 2026, down 8.62% YoY from $23.8 million in Q1 2025, and up 35.31% on a QoQ basis from $16.1 million in Q4 2025.

Analysis

Arrowhead Pharmaceuticals (ARWR) Prepaid Assets (2010 - 2026) Analysis & Trends

Arrowhead Pharmaceuticals (ARWR) has 17 years of Prepaid Assets data on file, last reported at $21.7 million in Q1 2026.

  • Quarterly Prepaid Assets fell 8.62% year-over-year to $21.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.7 million (down 8.62% YoY) and the FY2025 annual result came in at $13.5 million, up 171.79% from the prior year.
  • Prepaid Assets grew to $21.7 million in Q1 2026, from $16.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $23.8 million in Q1 2025 to a low of $4.0 million in Q3 2023.
  • A 5-year average of $11.9 million and a median of $10.1 million in 2023 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets soared 363.18% — and 2023, when it slumped 80.04%.
  • Tracing ARWR's Prepaid Assets over 5 years: stood at $8.4 million in 2022, then declined by 15.55% to $7.1 million in 2023, then jumped by 31.84% to $9.4 million in 2024, then jumped by 71.4% to $16.1 million in 2025, then soared by 35.31% to $21.7 million in 2026.
  • The last three Prepaid Assets figures came in at $21.7 million (Q1 2026), $16.1 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Arrowhead Pharmaceuticals 12.40 Bn 10.80 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.52 Mn
Mar 31, 2026 21.72 Mn
Dec 31, 2025 22.86 Mn
Sep 30, 2025 13.52 Mn
Jun 30, 2025 23.69 Mn
Mar 31, 2025 23.77 Mn
Dec 31, 2024 9.37 Mn
Sep 30, 2024 9.54 Mn
Jun 30, 2024 9.21 Mn
Mar 31, 2024 11.02 Mn
Dec 31, 2023 10.52 Mn
Sep 30, 2023 8.81 Mn
Jun 30, 2023 10.05 Mn
Mar 31, 2023 14.44 Mn
Dec 31, 2022 25.19 Mn
Sep 30, 2022 20.20 Mn
Jun 30, 2022 8.89 Mn
Mar 31, 2022 7.80 Mn
Dec 31, 2021 5.20 Mn
Sep 30, 2021 4.36 Mn